Publication | Open Access

Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

AsthmaUncontrolled Atopic DermatitisAtopic DermatitisPediatricsClinical DermatologyDermatologyMedicine